U.S. Household Products Stock News

Warrior Met Coal recently reported past first-quarter results showing much higher revenue and adjusted EBITDA, as the Blue Creek mine completed major construction ahead of schedule and began meaningfully contributing to operations. At the same time, institutional investors reshuffled their positions while management reaffirmed full-year guidance, suggesting that the shift from heavy project spending to production at Blue Creek is materially changing the company’s risk and cash flow...

Recent commentary on DraftKings (DKNG) has focused on continued operating strength into the second quarter and the launch of a new Combos feature on its prediction market platform, drawing fresh attention to the stock. See our latest analysis for DraftKings. The recent 12.97% 30 day share price return and 14.12% 90 day share price return suggest momentum is building again, although the share price is still down 27.71% year to date and the 1 year total shareholder return has declined...

Johnson & Johnson (NYSE:JNJ) reported positive Phase 2 data for JNJ-1900 (NBTXR3) in non small cell lung cancer. The company also released network meta analysis findings for CAPLYTA in major depressive disorder, comparing its effectiveness and safety with other treatments. These updates highlight fresh progress in Johnson & Johnson's oncology and neuroscience pipelines beyond its recent MedTech launches. For investors watching NYSE:JNJ, these clinical and comparative effectiveness data...

Stock performance snapshot Campbell's (CPB) stock has been under pressure, with the price around $20.34 and total returns down over the past month, past 3 months, year, and 5 years, while the company has reported modest annual revenue and net income growth. See our latest analysis for Campbell's. Recent trading has been choppy, with a 1-day share price return of 1.65% but a year-to-date share price return down 26.60%, and a 1-year total shareholder return down 39.30%, suggesting momentum has...

If you are trying to work out whether Strategy at around US$166.63 is a bargain or a value trap, the starting point is understanding what the current share price actually reflects. The stock has been choppy, with the price down about 15% over the last week, roughly flat over the past month at up 0.1%, up 6.0% year to date, yet down 59.7% over the last year and still showing a very large gain over three years. Recent coverage has focused on how the share price pullback over the past year...

Mineralys Therapeutics recently reported a first-quarter 2026 net loss of US$39.34 million and announced that it will present Phase 3 Launch-HTN data for its lead candidate lorundrostat in uncontrolled hypertension and chronic kidney disease at the European Meeting on Hypertension and Cardiovascular Protection on May 30, 2026. This upcoming disclosure of late-stage efficacy and safety results for lorundrostat in a complex patient group could meaningfully influence how investors assess...

Delhi High Court has ordered Apple to fully cooperate with the Competition Commission of India in an ongoing iPhone app market antitrust probe. The directive reflects intensifying regulatory scrutiny of Apple’s App Store practices in India, a key growth market for the company. The outcome of the probe could influence how Apple manages its platform, developer relationships, and compliance in the country. For investors watching NasdaqGS:AAPL, this legal development comes at a time when the...

Equifax (EFX) is back in focus after a class action lawsuit alleged widespread errors in consumer credit files, just as hotter April producer price inflation pressured the stock and highlighted broader cost concerns. See our latest analysis for Equifax. Despite a 3.7% 1 day share price gain to US$164.23, Equifax’s share price is down 23.3% year to date and the 1 year total shareholder return is down 40.9%. This suggests momentum has been fading as investors weigh legal and inflation related...

In early May 2026, Diamondback Energy reported stronger-than-expected Q1 results, raised its full-year production guidance, lifted its quarterly dividend to US$1.10 per share, and continued refocusing on core Permian Basin assets through debt reduction and divestitures. While several insiders disclosed routine share sales linked to equity awards, the company’s improved operations and higher cash generation appear to be the more significant drivers reshaping its outlook. We’ll now examine how...

Allient stock moves draw attention after recent performance shifts Allient (ALNT) has drawn fresh attention after a mixed stretch of returns, with the stock down about 18% over the past month but still showing a gain year to date. That contrast, together with 5.6% annual revenue growth and 17.9% annual net income growth on revenue of US$560.59 million and net income of US$23.83 million, is prompting investors to reassess what they are paying for the company’s motion control business. See our...

Why EagleRock Land Moved and What It Means for Investors EagleRock Land (EROK) drew investor attention after a single day move of 6.7%, with the stock closing at US$23. That shift puts a spotlight on how the company’s land and water assets are currently being valued. See our latest analysis for EagleRock Land. The 6.7% 1 day share price return comes on top of a 5.3% year to date share price return, which suggests that momentum in EagleRock Land has recently been building rather than...

Why Block's latest earnings and AI pivot matter for stock watchers Block (XYZ) has drawn fresh attention after Q1 2026 earnings, a major workforce reduction tied to AI driven productivity goals, and a higher full year earnings outlook that investors appeared to welcome. See our latest analysis for Block. Recent news has arrived in the middle of a strong 90 day share price return of about 39%, while the 1 year total shareholder return of roughly 21% shows that shorter term momentum has picked...

For readers wondering whether Qorvo at around US$94 per share still offers value, or if the easier gains have already been realized, this article breaks down what the current price might be implying about the stock. The stock has returned 0.9% over the past week and 15.0% over the past month, with a 9.2% return year to date. The 1-year return sits at 19.5%, while the 3- and 5-year returns reflect declines of 2.0% and 47.3% respectively. These figures can influence how investors think about...

FinVolution Group recently reported higher revenues and a growing base of registered users, while also announcing plans to expand into Pakistan and other international markets, alongside a dividend increase and new share buyback program. This combination of international expansion and increased capital returns highlights management’s focus on scaling its AI-powered fintech platform while rewarding existing shareholders. We’ll now examine how FinVolution’s planned push into Pakistan and other...

Earlier in 2026, EMCOR Group reported a sharp increase in data center infrastructure revenues tied to AI-related demand, prompting management to raise full-year 2026 revenue and EPS guidance while also scheduling multiple investor conference appearances and disclosing further insider share sales. This combination of AI-fueled data center growth, higher guidance, and active investor outreach underscores how central digital infrastructure has become to EMCOR’s project mix and future workload...

Packaging Corporation of America recently announced a 20% increase in its annual dividend to US$6.00 per share, with the first higher quarterly payment of US$1.50 per share scheduled for July 15, 2026 to shareholders of record on June 15, 2026. This larger payout, alongside a current dividend yield of 2.29% and a payout ratio of 50% of earnings, highlights how the company is using its cash flows to reward shareholders while maintaining room for reinvestment. We will now examine how this...

Wondering if Abbott Laboratories at around US$87.91 is a bargain or a value trap? This article breaks down what the current price might really be telling you. The stock has been volatile recently, with a 6.5% gain over the last week but a 9.2% decline over the last month. It is currently down 29.2% year to date and 33.8% over the past year. Recent headlines have focused on Abbott Laboratories' role within the broader healthcare sector and how investors are reassessing risk and return across...

Wondering whether Insight Enterprises at US$90.59 is offering value or just noise at the current price? This article walks you through what the numbers are actually saying about the stock. The share price has risen 2.7% over the last 7 days and 18.5% over the last 30 days, although it is still down 33.0% over the past year and 12.1% over 5 years. This combination of moves can change how you think about both risk and potential reward. These moves are drawing more attention to Insight...

Wondering whether Impinj at around US$139 per share still offers value or if the market has already priced in the story? This article walks through what the current price might be implying. The stock has been volatile recently, with a 7 day return that declined 9.4%, a 30 day return of 24.1%, a year to date return that declined 22.5% and a 1 year return of 13.0%, while the 3 year return is 41.2% and the 5 year return is 174.2%. These moves come as investors continue to reassess where Impinj...

United Airlines Holdings (NasdaqGS:UAL) is launching the first nonstop flights from the continental U.S. to Sapporo, Japan, along with new daily Chicago to Tokyo Narita service. The company is expanding its reciprocal loyalty program integration with JetBlue, allowing broader perks, shared bookings, and point redemption across both networks. United also plans to resume Houston to Caracas service, reopening a key travel and economic corridor after an extended suspension. For you as an...

SolarEdge Technologies (SEDG) has been in focus after Q1 2026 results showed revenue of US$310.5 million, narrowing losses and Q2 guidance of US$325 million to US$355 million, alongside a surge in tax credit driven demand. See our latest analysis for SolarEdge Technologies. At a share price of US$55.23, SolarEdge has had a sharp swing in sentiment, with a 76.12% year to date share price return and a 166.04% one year total shareholder return, even though the three and five year total...

Wondering if Intuit at US$403.16 is pricing in too much hope or still offering value? This article breaks down what the current share price might be implying. The stock has inched up 2.5% over the past week and 2.5% over the past month, but is still down 36.0% year to date and has declined 39.4% over the past year. This may change how you think about its risk and return profile. Recent coverage has focused on how Intuit is positioned in software and financial tools, along with investor...

Garrett Motion (GTX) is in focus after repricing its US$635 million term loan, making a US$50 million early repayment and entering a multiyear oil free air technology partnership with Ingersoll Rand. See our latest analysis for Garrett Motion. The recent loan repricing and the Ingersoll Rand partnership come after a strong run, with the share price up 52.59% over 30 days and the 1 year total shareholder return at 159.13%. Together with a 5 year total shareholder return of 320.01%, this points...

In the first quarter ended March 31, 2026, Calumet, Inc. reported sales of US$1,029.7 million, up from US$993.9 million a year earlier, while net loss widened to US$317 million from US$162 million. This combination of higher revenue but a much larger loss highlights the pressure on profitability even as Calumet grows its top line. Next, we’ll examine how Calumet’s sharply higher quarterly net loss may influence its existing investment narrative and risk profile. Invest in the nuclear...